What is the recommended treatment for typhoid fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Typhoid Fever

Azithromycin 500 mg once daily for 7 days is the preferred first-line treatment for typhoid fever in adults, particularly given widespread fluoroquinolone resistance exceeding 70% in South Asia. 1, 2

First-Line Treatment Regimen

  • Azithromycin is the drug of choice for empiric treatment of typhoid fever, especially for cases originating from South Asia where fluoroquinolone resistance approaches 96% in some regions 1, 2
  • Adult dosing: Azithromycin 500 mg once daily orally for 7-14 days 1, 2, 3
  • Pediatric dosing: Azithromycin 20 mg/kg/day (maximum 1g/day) for 7 days 1, 2

Why Azithromycin Over Other Options

Azithromycin demonstrates superior clinical outcomes compared to alternatives:

  • Lower clinical failure rate: OR 0.48 (95% CI 0.26-0.89) compared to fluoroquinolones 1, 2
  • Shorter hospital stays: Approximately 1 day shorter than fluoroquinolones (mean difference -1.04 days) 1, 2
  • Dramatically lower relapse risk: OR 0.09 (95% CI 0.01-0.70) compared to ceftriaxone 1, 2
  • Faster fever clearance: Mean 5.8 days with azithromycin versus 7.1 days with cefixime and 8.2 days with ciprofloxacin 4

Alternative Treatment Options (When Azithromycin Cannot Be Used)

Ceftriaxone

  • Adult dosing: 1-2g IV/IM daily for 5-7 days 1
  • Pediatric dosing: 50-80 mg/kg/day (maximum 2g/day) IV/IM for 5-7 days 1
  • Use for severe cases or when oral therapy is not feasible 3
  • May have higher relapse rates compared to azithromycin 1

Fluoroquinolones (Only if Susceptibility Confirmed)

  • Ciprofloxacin or ofloxacin remain effective when susceptibility is documented 1, 5
  • Critical caveat: Ciprofloxacin is FDA-approved for typhoid fever but shows 18.1% resistance rates in some studies 5, 6
  • The FDA label indicates ciprofloxacin for typhoid fever caused by Salmonella typhi, but this predates widespread resistance 5

Treatment Algorithm Based on Geographic Origin

For cases from South or Southeast Asia:

  • Start azithromycin immediately - do NOT use ciprofloxacin empirically 1, 2
  • Fluoroquinolone resistance exceeds 70% and approaches 96% in these regions 1, 2

For cases from other regions with known susceptibility:

  • Fluoroquinolones may be considered if local resistance patterns permit 1, 3
  • Always obtain blood cultures before starting antibiotics when possible 1, 2

Critical Diagnostic Steps

  • Obtain blood cultures before initiating antibiotics - highest yield within the first week of symptom onset 1, 2
  • For patients with sepsis features, start broad-spectrum therapy immediately after collecting cultures 1, 3
  • Blood or bone marrow culture remain the reference standard despite low sensitivity of blood culture 7

Expected Clinical Response and Monitoring

  • Fever should clear within 4-5 days of appropriate antibiotic therapy 1, 2, 3
  • If no clinical improvement by day 5, consider antimicrobial resistance or alternative diagnosis 1
  • Monitor for common azithromycin adverse effects: nausea, vomiting, abdominal pain, and diarrhea 1, 2, 3
  • Watch for QT-prolonging drug interactions with azithromycin 1, 2

Critical Pitfalls to Avoid

  • Never discontinue antibiotics prematurely - complete the full 7-day course even if fever resolves early, as relapse occurs in 10-15% of inadequately treated cases 1, 2, 3
  • Never use ciprofloxacin empirically for South/Southeast Asian cases - resistance is nearly universal 1, 2, 3
  • Avoid cefixime as first-line therapy - documented treatment failure rates of 4-37.6% and requires mandatory test-of-cure at 1 week if used 1, 8
  • Do not use combination typhoid-paratyphoid vaccines; only monovalent S. typhi preparations should be used 9, 1

Management of Complications

  • Intestinal perforation occurs in 10-15% of patients when illness duration exceeds 2 weeks 1, 2
  • Requires immediate surgical intervention with simple excision and closure, successful in up to 88.2% of cases 1, 2
  • Watch for life-threatening complications that can arise in the second week of untreated illness 7

Prevention Strategies

  • Typhoid vaccination is recommended for travelers to endemic areas (Latin America, Asia, Africa) 9, 1, 2
  • Two vaccine types available: Ty21a oral vaccine (4 doses on alternate days, refrigerated) and Vi-polysaccharide parenteral vaccine 9, 1
  • Important limitation: Vaccination provides only 50-80% protection and does NOT protect against Salmonella Paratyphi 1, 2, 7
  • Ty21a oral vaccine requires booster every 5 years; parenteral vaccine every 3 years 1
  • Hand hygiene and food/water safety precautions remain essential and cannot be replaced by vaccination alone 1, 2

References

Guideline

Management of Typhoid Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Typhoid Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Typhoid Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Study of clinical profile and antibiotic response in typhoid fever.

Indian journal of medical microbiology, 2005

Research

Enteric (typhoid and paratyphoid) fever.

Lancet (London, England), 2025

Research

Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.

The Cochrane database of systematic reviews, 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.